Cost-effectiveness of different human papillomavirus vaccines in Singapore

Cost-effectiveness of different human papillomavirus vaccines in Singapore

<p>Abstract</p> <p>Background</p> <p>Human papillomavirus (HPV) vaccines are widely available and there have been studies exploring their potential clinical impact and cost-effectiveness. However, few studies have compared the cost-effectiveness among the 2 main vaccine...

Full description

Bibliographic Details
Main Authors:	Tay Sun, Lee Vernon J, Teoh Yee, Tok Mei
Format:	Article
Language:	English
Published:	BMC 2011-03-01
Series:	BMC Public Health
Subjects:	Cervical cancer cervical intraepithelial neoplasia incremental cost effectiveness ratio vaccine
Online Access:	http://www.biomedcentral.com/1471-2458/11/203

Similar Items

Cost-effectiveness analysis of different types of human papillomavirus vaccination combined with a cervical cancer screening program in mainland China
by: Xiuting Mo, et al.
Published: (2017-07-01)

The Human Papillomavirus Infection Characteristics for Patients with Cervical Intraepithelial Neoplasia in Yunnan, China: A Sampling Survey Analysis
by: Zhi HF, et al.
Published: (2022-06-01)

Human papillomavirus genotype distribution and socio-behavioural characteristics in women with cervical pre-cancer and cancer at the start of a human papillomavirus vaccination programme: the CIN3+ plus study
by: Dianne Egli-Gany, et al.
Published: (2019-01-01)

The efficacy of human papillomavirus vaccination in young Japanese girls: the interim results of the OCEAN study
by: Kosuke Hiramatsu, et al.
Published: (2022-01-01)

Monitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008–2012
by: Susan Hariri, et al.
Published: (2015-09-01)

Effectiveness of human papillomavirus vaccination in young Japanese women: a retrospective multi-municipality study
by: Akiko Tozawa-Ono, et al.
Published: (2021-04-01)

Human papillomavirus infection – new perspectives on diagnosis and treatment (review)
by: N V Bestaeva, et al.
Published: (2013-06-01)

Epidemiology and genotype distribution of human papillomavirus (HPV) in Southwest China: a cross-sectional five years study in non-vaccinated women
by: Yishu Tang, et al.
Published: (2017-04-01)

Papillomavirus in cervicovaginal smears of women infected with human immunodefficiency virus
by: Edenilson Eduardo Galore, et al.

Topical imiquimod treatment for human papillomavirus infection in patients with and without cervical/vaginal intraepithelial neoplasia
by: Cheng-Tao Lin, et al.
Published: (2012-12-01)

Human papillomavirus-associated anal and cervical neoplasia: evaluation of vaccino-prophylaxis programs
by: N. M. Nazarova, et al.
Published: (2018-04-01)

Detection of Human Papillomavirus Types 16 and 18 by Polymerase Chain Reaction in Cervical Biopsy Specimens
by: Serdar TUNCER, et al.
Published: (1996-03-01)

Vaccination against human papillomavirus after adjuvant therapy of cervical intraepithelial neoplasia
by: I. I. Kutsenko, et al.
Published: (2022-06-01)

Human Papillomavirus Distribution in Women with Abnormal Pap Smear and/or Cervical Intraepithelial Neoplasia in Vaccination Era. A Single-Center Study in the North Italian Population
by: Barbara Gardella, et al.
Published: (2021-03-01)

Prophylactic HPV vaccines
by: Mandić Aljoša
Published: (2009-01-01)

CERVICAL SQUAMOUS EPITHELIUM LESIONS ASSOCIATED WITH HUMAN PAPILLOMAVIRUS INFECTION
by: V. A. Еrshov, et al.
Published: (2014-07-01)

ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening
by: HC Kitchener, et al.
Published: (2009-11-01)

What influence does vaginal microbiota have on Human Papillomavirus infection?
by: José Eleutério Junior, et al.
Published: (2020-12-01)

Cervical Intraepithelial Neoplasia Grade 3 in a HPV-Vaccinated Patient: A Case Report
by: Mateja Sladič, et al.
Published: (2022-02-01)

Diagnostic markers of human papillomavirus persistence and progression of cervical intraepithelial neoplasia
by: O. V. Khoperskaya, et al.
Published: (2022-01-01)

Changes in HPV16/18 Prevalence among Unvaccinated Women with Cervical Intraepithelial Neoplasia in Japan: Assessment of Herd Effects following the HPV Vaccination Program
by: Mamiko Onuki, et al.
Published: (2022-01-01)

Post-hoc analysis from phase III trials of human papillomavirus vaccines: considerations on impact on non-vaccine types
by: Martin Ryser, et al.
Published: (2019-03-01)

Human papillomavirus infection and cervical intraepithelial neoplasia progression are associated with increased vaginal microbiome diversity in a Chinese cohort
by: Yulian Chen, et al.
Published: (2020-08-01)

Pathological discrepancy between colposcopic directed cervical biopsy and Loop Electrosurgical-Excision Procedures (LEEPs) in patients with biopsies proven high grade cervical intraepithelial neoplasia
by: Sitchuphong Noothong, et al.
Published: (2017-10-01)

The Efficacy of Therapeutic DNA Vaccines Expressing the Human Papillomavirus E6 and E7 Oncoproteins for Treatment of Cervical Cancer: Systematic Review
by: Ayazhan Akhatova, et al.
Published: (2021-12-01)

Effects of the Prophylactic HPV Vaccines on HPV Type Prevalence and Cervical Pathology
by: Ian N. Hampson
Published: (2022-04-01)

HPV Vaccination: The Position Paper of the Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV)
by: Andrea Ciavattini, et al.
Published: (2020-07-01)

The occurrence of human papillomavirus types in the formation of neoplastic transformation of the epithelium of the cervix in “lesser abnormalies”
by: Elena G. Sycheva, et al.
Published: (2020-05-01)

Limited Role of Promoter Methylation of MGMT and C13ORF18 in Triage of Low-Grade Squamous Intraepithelial Lesion
by: Lu-Lu Sun, et al.
Published: (2018-01-01)

HPV vaccination impact on a cervical cancer screening program: methods of the FASTER-Tlalpan Study in Mexico
by: Jorge Salmerón, et al.
Published: (2016-03-01)

Differences on the prevalence of cervical HPV between Lithuania and Belarus
by: Gudleviciene Zivile, et al.
Published: (2014-04-01)

Age-related Features of the Cytological Diagnosis of Cervical Dysplasia of Different Degrees
by: Maria Kirillina, et al.
Published: (2019-12-01)

A single-institutional retrospective analysis of factors related to vaginal intraepithelial neoplasia
by: Hongmin Zeng, et al.
Published: (2023-10-01)

Human papillomavirus types in cervical high‐grade lesions or cancer among Nordic women—Potential for prevention
by: Cecilie Dovey de la Cour, et al.
Published: (2019-02-01)

Oncogenic high-risk human papillomavirus detection and evaluation of risk factors in the cervical intraepithelial neoplasia I
by: Edison Natal Fedrizzi, et al.
Published: (2022-04-01)

Human papillomavirus-associated cervical intraepithelial neoplasia in the presence of iodine deficiency
by: I. V. Sahautdinova, et al.
Published: (2021-10-01)

The Value of MicroRNA-375 Detection for Triaging Primary Human Papillomavirus Positive Women: A Cross-Sectional Study in a General Population
by: Qiongyan Wu, et al.
Published: (2021-10-01)

Risk factors for human papillomavirus infection, cervical intraepithelial neoplasia and cervical cancer: an umbrella review and follow-up Mendelian randomisation studies
by: Sarah J. Bowden, et al.
Published: (2023-07-01)

Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed
by: Takeo Shibata, et al.
Published: (2021-09-01)

Relationship between vaginal microecology and human papillomavirus infection as well as cervical intraepithelial neoplasia in 2,147 women from Wenzhou, the southeast of China
by: Lejing Zang, et al.
Published: (2024-01-01)